Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment

Cystic fibrosis (CF) patients characteristically have severe chronic airway inflammation associated with bacterial infection. A noninvasive marker of airway inflammation could be a useful guide to treatment of CF lung disease. The aim of this study was to assess whether measurement of hydrogen peroxide (H2O2) and nitric oxide (NO) in exhaled air can serve to monitor the effect of treatment with antibiotics in CF-children with acute infective pulmonary exacerbations. Sixteen CF-patients (mean age 12.3 yrs) with exacerbation of their lung infection were treated with intravenous antibiotics in an uncontrolled study. During treatment, H2O2 in exhaled air condensate was measured twice a week. In addition, serial NO measurements were performed in nine patients. During antibiotic treatment the median H2O2 concentration in exhaled air condensate decreased significantly from 0.28 microM (range 0.07-1.20 microM) to 0.16 microM (range 0.05-0.24 microM, p=0.002) and the mean forced expiratory volume in one second significantly increased from 55% predicted to 75% pred (p=0.001). In individual subjects, changes of H2O2 and FEV1 between pairs of serial measurements correlated weakly (p=0.08). Data on exhaled NO were inconclusive; exhaled NO did not change systematically during treatment. It is concluded that cystic fibrosis patients with an acute pulmonary exacerbation have abnormally high concentrations of hydrogen peroxide, but not of nitric oxide, in exhaled air, which decrease during intravenous antibiotic treatment. Further controlled studies should establish if exhaled hydrogen peroxide, may serve as a noninvasive parameter of airway inflammation to guide antibiotic treatment in cystic fibrosis lung disease.

This article has been cited by other articles:

				M. D. P. Willcox, H. Zhu, T. C. R. Conibear, E. B. H. Hume, M. Givskov, S. Kjelleberg, and S. A. Rice Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis Microbiology, August 1, 2008; 154(8): 2184 - 2194. [Abstract] [Full Text] [PDF]

				P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF]

				A. R. Wewel, J. A. M. Crusius, U. Gatzemeier, M. Heckmayr, G. Becher, H. Magnussen, R. A. Jorres, and O. Holz Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur. Respir. J., May 1, 2006; 27(5): 1033 - 1039. [Abstract] [Full Text] [PDF]

				I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]

				A. J. Kettle, T. Chan, I. Osberg, R. Senthilmohan, A. L. P. Chapman, T. J. Mocatta, and J. S. Wagener Myeloperoxidase and Protein Oxidation in the Airways of Young Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1317 - 1323. [Abstract] [Full Text] [PDF]

				J B McCafferty, T A Bradshaw, S Tate, A P Greening, and J A Innes Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations Thorax, August 1, 2004; 59(8): 694 - 698. [Abstract] [Full Text] [PDF]

				G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov Breath Condensate pH in Children With Cystic Fibrosis and Asthma: A New Noninvasive Marker of Airway Inflammation? Chest, June 1, 2004; 125(6): 2005 - 2010. [Abstract] [Full Text] [PDF]

				S. W. Terheggen-Lagro, M. W. Bink, H. J. Vreman, and C. K. van der Ent End-Tidal Carbon Monoxide Corrected for Lung Volume Is Elevated in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1227 - 1231. [Abstract] [Full Text] [PDF]

				C. Wijkstrom-Frei, S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M. A. Cobas, R. Forteza, M. Salathe, and G. E. Conner Lactoperoxidase and Human Airway Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 206 - 212. [Abstract] [Full Text] [PDF]

				E Baraldi, S Carraro, R Alinovi, A Pesci, L Ghiro, A Bodini, G Piacentini, F Zacchello, and S Zanconato Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations Thorax, June 1, 2003; 58(6): 505 - 509. [Abstract] [Full Text] [PDF]

				G. E. Carpagnano, P. J. Barnes, D. M. Geddes, M. E. Hodson, and S. A. Kharitonov Increased Leukotriene B4 and Interleukin-6 in Exhaled Breath Condensate in Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1109 - 1112. [Abstract] [Full Text] [PDF]

				G. Vass, E. Huszar, E. Barat, M. Valyon, D. Kiss, I. Penzes, M. Augusztinovicz, and I. Horvath Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 850 - 855. [Abstract] [Full Text] [PDF]

				M. Corradi, G. Folesani, R. Andreoli, P. Manini, A. Bodini, G. Piacentini, S. Carraro, S. Zanconato, and E. Baraldi Aldehydes and Glutathione in Exhaled Breath Condensate of Children with Asthma Exacerbation Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 395 - 399. [Abstract] [Full Text] [PDF]

				S Tate, G MacGregor, M Davis, J A Innes, and A P Greening Airways in cystic fibrosis are acidified: detection by exhaled breath condensate Thorax, November 1, 2002; 57(11): 926 - 929. [Abstract] [Full Text] [PDF]

				R. M. EFFROS, K. W. HOAGLAND, M. BOSBOUS, D. CASTILLO, B. FOSS, M. DUNNING, M. GARE, W. LIN, and F. SUN Dilution of Respiratory Solutes in Exhaled Condensates Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 663 - 669. [Abstract] [Full Text] [PDF]

				B. GASTON, F. RATJEN, J. W. VAUGHAN, N. R. MALHOTRA, R. G. CANADY, A. H. SNYDER, J. F. HUNT, S. GAERTIG, and J. B. GOLDBERG Nitrogen Redox Balance in the Cystic Fibrosis Airway . Effects of Antipseudomonal Therapy Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 387 - 390. [Abstract] [Full Text] [PDF]

				G. M. MUTLU, K. W. GAREY, R. A. ROBBINS, L. H. DANZIGER, and I. RUBINSTEIN Collection and Analysis of Exhaled Breath Condensate in Humans Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 731 - 737. [Full Text] [PDF]

				S. A. KHARITONOV and P. J. BARNES Exhaled Markers of Pulmonary Disease Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1693 - 1722. [Full Text] [PDF]